Literature DB >> 18640629

Complementary therapy use by persons with multiple sclerosis: benefits and research priorities.

Lisa Esmonde1, Andrew F Long.   

Abstract

People with multiple sclerosis (MS) are commonly actively involved in self-care, with many accessing complementary and alternative medicine (CAM) to help in symptom management. To provide increased insight into benefits from CAM use and service user ideas over research priorities, a two-part study, involving a questionnaire and interactive workshop, was undertaken with attendees at a national Congress of the MS Trust in the UK. The six most used therapies were reflexology, massage, yoga, relaxation and meditation, acupuncture and aromatherapy. Each was rated by a quarter to two-fifths as 'extremely helpful'. Insight into the nature of the therapeutic benefit was provided in user comments. Despite the self-selected nature of the sample, the findings point to potential benefits of a set of CAM therapies in helping people with MS. More research on potential benefits of therapies was called for by participants and on the dynamics of the therapeutic effect.

Entities:  

Mesh:

Year:  2008        PMID: 18640629     DOI: 10.1016/j.ctcp.2008.03.001

Source DB:  PubMed          Journal:  Complement Ther Clin Pract        ISSN: 1744-3881            Impact factor:   2.446


  20 in total

Review 1.  Therapeutic Yoga: Symptom Management for Multiple Sclerosis.

Authors:  Kim A Rogers; Megan MacDonald
Journal:  J Altern Complement Med       Date:  2015-08-13       Impact factor: 2.579

2.  Evaluation of the effect of progressive relaxation exercises on fatigue and sleep quality in patients with multiple sclerosis.

Authors:  Nuray Dayapoğlu; Mehtap Tan
Journal:  J Altern Complement Med       Date:  2012-09-11       Impact factor: 2.579

Review 3.  The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.

Authors:  A Tubaro; F Puccini; C De Nunzio; G A Digesu; S Elneil; C Gobbi; V Khullar
Journal:  Curr Urol Rep       Date:  2012-10       Impact factor: 3.092

4.  Feasibility and Impact of an 8-Week Integrative Yoga Program in People with Moderate Multiple Sclerosis-Related Disability: A Pilot Study.

Authors:  Evan T Cohen; David Kietrys; Susan Gould Fogerite; Mariella Silva; Kristen Logan; Donald A Barone; J Scott Parrott
Journal:  Int J MS Care       Date:  2017 Jan-Feb

5.  Cinnamon extract induces tumor cell death through inhibition of NFkappaB and AP1.

Authors:  Ho-Keun Kwon; Ji-Sun Hwang; Jae-Seon So; Choong-Gu Lee; Anupama Sahoo; Jae-Ha Ryu; Won Kyung Jeon; Byoung Seob Ko; Sung Haeng Lee; Zee Yong Park; Sin-Hyeog Im
Journal:  BMC Cancer       Date:  2010-07-24       Impact factor: 4.430

Review 6.  Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys.

Authors:  Paul Posadzki; Leala K Watson; Amani Alotaibi; Edzard Ernst
Journal:  Clin Med (Lond)       Date:  2013-04       Impact factor: 2.659

7.  Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial.

Authors:  Adelaida María Castro-Sánchez; Guillermo A Matarán-Peñarrocha; Inmaculada Lara-Palomo; Manuel Saavedra-Hernández; Manuel Arroyo-Morales; Carmen Moreno-Lorenzo
Journal:  Evid Based Complement Alternat Med       Date:  2011-07-14       Impact factor: 2.629

8.  Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries.

Authors:  L Skovgaard; P H Nicolajsen; E Pedersen; M Kant; S Fredrikson; M Verhoef; D W Meyrowitsch
Journal:  Autoimmune Dis       Date:  2012-12-11

9.  Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis.

Authors:  Mohammad Hossein Harirchian; Mohammad Ali Sahraian; Amir Hosseinkhani; Nasibeh Amirzargar
Journal:  Iran J Neurol       Date:  2014

Review 10.  Uses of complementary and alternative medicine in multiple sclerosis.

Authors:  Foroogh Namjooyan; Rahil Ghanavati; Nastaran Majdinasab; Shiva Jokari; Mohammad Janbozorgi
Journal:  J Tradit Complement Med       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.